Metabolomics studies in cushing's syndrome: recent developments and perspectives

Area of Science:

• Endocrinology
• Metabolomics
• Biomarker Discovery

Background:

• Cushing's syndrome, characterized by excessive glucocorticoids, presents diagnostic challenges.
• Exogenous Cushing's results from external glucocorticoid exposure, while endogenous forms stem from internal overproduction.
• Mass spectrometry (MS) has advanced disease mechanism understanding and personalized medicine.

Purpose of the Study:

• To review the application of mass spectrometry-based metabolomics in evaluating Cushing's syndrome.
• To explore the diagnostic potential of metabolomic approaches for both endogenous and exogenous Cushing's syndrome.
• To highlight the role of MS in identifying novel biomarkers for precision medicine.

Main Methods:

• Review of existing literature on mass spectrometry-based metabolomic studies in Cushing's syndrome.
• Discussion of the capabilities of MS in metabolite detection, resolution, and specificity.
• Exploration of multi-omics approaches for developing molecular diagnostic tests.

Main Results:

• Limited studies exist on MS-metabolomics for endogenous Cushing's, with less exploration for exogenous forms.
• Global metabolomics can reveal altered metabolites and pathways relevant to Cushing's syndrome.
• MS facilitates the identification of potential biomarkers for personalized management.

Conclusions:

• Mass spectrometry-based metabolomics holds significant potential for diagnosing Cushing's syndrome.
• Further research is needed to fully leverage MS for both endogenous and exogenous Cushing's evaluation.
• Metabolomic and multi-omics strategies can drive the development of advanced diagnostic tools and precision medicine for Cushing's syndrome.